Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. | COO and General Counsel | Common Stock | 91.9K | $408K | $4.44 | May 31, 2024 | Direct |
Terns Pharmaceuticals, Inc. | COO and General Counsel | Stock Option (Right to Buy) | 138K | Jan 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TERN | Terns Pharmaceuticals, Inc. | May 31, 2024 | 1 | $21.3K | 4 | Jun 4, 2024 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | Jan 23, 2024 | 2 | $0 | 4 | Jan 25, 2024 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | Nov 30, 2023 | 1 | $2.81K | 4 | Dec 4, 2023 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | May 31, 2023 | 1 | $14.1K | 4 | Jun 2, 2023 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | Feb 1, 2023 | 2 | $4.23 | 4 | Feb 3, 2023 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | May 31, 2022 | 1 | $11.3K | 4 | Jun 8, 2022 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | COO and General Counsel |
TERN | Terns Pharmaceuticals, Inc. | Sep 28, 2021 | 1 | $0 | 4 | Sep 30, 2021 | COO and General Counsel |